Begrivac

Pays: Nouvelle-Zélande

Langue: anglais

Source: Medsafe (Medicines Safety Authority)

Ingrédients actifs:

Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15ug; Influenza virus haemagglutinin type A/New Caledonia/20/99 H1N1-like strain 15ug; Influenza virus haemagglutinin type B/Sichuan/379/99 - like strain 15ug

Disponible depuis:

Novartis New Zealand Ltd

DCI (Dénomination commune internationale):

Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15 µg

Dosage:

0.5 mL

forme pharmaceutique:

Suspension for injection

Composition:

Active: Influenza virus haemagglutinin type A/Moscow/10/99 H3N2 - like strain 15ug Influenza virus haemagglutinin type A/New Caledonia/20/99 H1N1-like strain 15ug Influenza virus haemagglutinin type B/Sichuan/379/99 - like strain 15ug Excipient: Ether Formaldehyde Phosphate Buffered Saline Polymyxin B Polysorbate 80 Sucrose

Unités en paquet:

Syringe, glass, Prefilled single 0.5ml dose, 1 dose unit

classe:

Prescription

Type d'ordonnance:

Prescription

Fabriqué par:

GSK Vaccines GmbH

Descriptif du produit:

Package - Contents - Shelf Life: Syringe, glass, Prefilled single 0.5ml dose - 1 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) - Syringe, glass, 0.5mL syringe, 10 pack - 10 dose units - 12 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Date de l'autorisation:

1999-11-12